Clobetasol propionate
Clobetasol propionate is a pharmaceutical drug with 16 clinical trials. Currently 2 active trials ongoing. Historical success rate of 90.0%.
Success Metrics
Based on 9 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
4
Mid Stage
8
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
81.8%
9 of 11 finished
18.2%
2 ended early
2
trials recruiting
16
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer
Plasma Rich in Growth Factors (PRGF) for the Treatment of Lichen Sclerosus Atrophicus of the Vulva
Efficacy of Topical Treatment With Clobetasol in Symptomatic Oral Lichen Planus.
Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% in the Treatment of Inflammation After Cataract Surgery in Pediatric Population
Rebamipide (Regular & Nanoparticulated) vs. Clobetasol in Management of Methotrexate-Induced Oral Ulceration in Rheumatoid Arthritis Patients
Clinical Trials (16)
Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer
Plasma Rich in Growth Factors (PRGF) for the Treatment of Lichen Sclerosus Atrophicus of the Vulva
Efficacy of Topical Treatment With Clobetasol in Symptomatic Oral Lichen Planus.
Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% in the Treatment of Inflammation After Cataract Surgery in Pediatric Population
Rebamipide (Regular & Nanoparticulated) vs. Clobetasol in Management of Methotrexate-Induced Oral Ulceration in Rheumatoid Arthritis Patients
Influence of Dermocorticoids on Bone Mineral Density in Patients With Bullous Pemphigoid
Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-2)
Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1)
Intra-oral Treatment of OLP With Rivelin®-CLO Patches
Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areata
Topical Betamethasone and Clobetasol in Orabase in Oral Lichen Planus
BAY1003803 Single and Multiple Dose Escalation, Safety, Tolerability and Pharmacokinetics Study
Vulvar Lichen Sclerosus: Comparison Between Clobetasol Propionate, Photodynamic Therapy and Low-Intensity Laser
A Study Assessing GW870086's Potential to Cause Skin Thinning
BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test
Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand Dermatitis
All 16 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 16